Tuesday, June 7, 2022
- 6:00pm-6:10pm
-
Enhanced Histological Yield and Actionable Findings When Biopsy is Guided by Donor-Derived Cell-Free DNA (dd-cfDNA)
Biomarkers: Clinical Outcomes II • Hynes Ballroom A
- 6:00pm-6:10pm
-
Evaluation of Hepatitis C Positive Donor to Hepatitis C Negative Recipient Kidney Transplant in a Highly Sensitized Patient Population
Viral Hepatitis • Hynes Room 312
- 6:00pm-6:10pm
-
Evolution of Pretransplant Cardiac Risk Factor Burden and Major Adverse Cardiovascular Events in Liver Transplant Recipients Over Time
Retransplantation and Other Complications • Hynes Room 313
- 6:00pm-6:10pm
-
HLA-DQ Mismatches Are More Likely to Be Listed as Unacceptable Antigens After Renal Graft Failure in African American Recipients as Compared to Other Racial/Ethnic Groups
Health Equity and Access II • Hynes Ballroom C
- 6:00pm-6:10pm
-
Impact of Cyp 3a5 Genotype on Lcp Tacrolimus Dosing and Monitoring in Kidney Transplantation
- 6:00pm-6:10pm
-
Possible Recurrence Must Not Limit Kidney Transplantations for Patients with Focal Segmental Glomerulosclerosis
Recurrent Kidney Disease & Genetics • Hynes Room 310
- 6:00pm-6:10pm
-
Predicting Long Term Kidney-Allograft Failure: Machine Learning vs Traditional Statistical Models
- 6:00pm-6:10pm
-
Seroprevalence of MMR and Varicella (MMRV) in Solid Organ Transplant Candidates and Seroresponse to MMRV Vaccinations
Quality Assurance Process Improvement & Regulatory Issues • Hynes Room 206
- 6:00pm-6:10pm
-
Strada Deficiency Results in Inhibition of Tumor Suppressor Gene Liver Kinase B1 Resulting in Epithelial Mesenchymal Transition Leading to Chronic Murine Lung Allograft Rejection
Chronic Organ Rejection • Hynes Room 309
- 6:00pm-6:10pm
-
T and B Cell Response to 3 Dose Covid Vaccine Series for Kidney Transplant Patients on Belatacept
Kidney Transplant Infections • Hynes Ballroom B
- «Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 52
- Next Page»